Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s Sup | The billionaire family behind former OxyContin maker Purdue Pharma was denied a bankruptcy protection deal in a high-profile Supreme Court ruling last summer.
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback